Discover Our Group:

Berlin-Chemie has been developing, manufacturing and distributing pharmaceutical products for over 130 years and has been a wholly owned subsidiary of the Menarini Group, the leading Italian pharmaceutical company, since 1992. 

Responsibility is a top priority at Berlin-Chemie. We not only make an important contribution to healthcare, but also put our values into practice through various social initiatives.

Discover More about Global Responsibility

From school kits to free meals and medicines, to caring for the environment around the world. In Menarini, being responsible means translating our values into concrete actions that are good for others and good for the planet

Berlin-Chemie – a strong partner. Our many years of experience and the success of joint projects make us the partner of choice. 

Discover More about Global Partnering

Menarini has in-depth know-how in many important therapeutic areas, thanks to many years of excellent market introduction, marketing and sales capabilities as well as expertise in regulatory aspects and market access. Collaboration is the key to great success, and at Menarini, partnership is part of the DNA.

Our holistic and professional health management offers doctors individual counselling, training or workshops, events and lectures on many topics, depending on their needs.

Our Medical Hub acts as a central point of contact for doctors and healthcare professionals. Here you will find all the information about our medications, additional service and training opportunities.

Welcome to the News & More section. Here you will find general information in the form of press releases, news and the latest graphical material. 

Menarini Blog

Follow Us

We employ professionals with a wide variety of career backgrounds and are employers who care about their staff. Together, we stand for innovation and reliability.

Our Job Portal

Find out about our current vacancies at Berlin-Chemie directly on our career portal.

Menarini Group News

2011 - 05 - 24

Presentation of the volume dedicated to ‘Bronzino’ to be held in Palazzo Barberini under the auspices of the Menarini Group

Menarini 125 anni

Palazzo Barberini


Rome, 24th May 2011

Tomorrow, 25th May 2011, the Menarini Group, in collaboration with Viviani Editore, will be presenting the volume dedicated to ‘Bronzino’ at Palazzo Barberini in Rome.

The monograph, edited by Professor Claudio Strinati, traces the career of one of Italy’s most famous mannerist painters, Agnolo Bronzino, permanently active in Florence as court artist under Duke Cosimo I de’ Medici and contemporary of Giorgio Vasari. A pupil of Jacopo Pontormo, Bronzino was a 16th century artist capable of toning down the darker and anti-classical works of his time whilst deftly maintaining intact the design and expressive power of both acrid colours and iridescent hues.

The presentation will commence at 18:00 in the splendid and majestic hall named after Pietro da Cortona in Palazzo Barberini.

Professor Rossella Vodret, Superintendent of the Historic, Artistic and Ethno-anthropological Museums of Rome will be opening the presentation along with Professors Claudia Cieri Via, and Alessandro Zuccari. The author, Professor Claudio Strinati, Superintendent in Rome for more than twenty years, shall also be present, accompanied by co-author Stefania Pasti.

" This volume is the latest addition to our collection of monographs on some of the Italy’s finest painters and sculptors, and we are proud to have been able to carry on the almost half a century tradition with such a wonderful work on ‘Bronzino’. This superb volume also recalls the magnificent exhibition recently put on in honour of this great 16th century artist," commented a member of the Menarini Group.

"A volume which is both rich and philological, capable of bringing readers truly close to this great Florentine artist" added Anna Lo Bianco, Director of Palazzo Barberini.

The event is sponsored by MIBAC, the Lazio Region, the Province of Rome and the Municipality of Rome.

The Menarini Group is the first Italian pharmaceutical company in the world, 15th in Europe out of 2,311 companies and 35th out of 4,641 companies world wide. The Group’s turnover is more than 3 billion Euro and currently employs 13,000 people all around the globe. The Menarini Group has always pursued two strategic objectives: Research and Internationalisation. The Group’s product range covers the most important therapeutic areas including: cardiovascular products, gastroenterological products, antibiotics and respiratory products, anti diabetes products, anti-inflammatory agents and analgesics. The Group has a strong presence throughout Europe and major countries in Asia, Africa, Central and South America. The Menarini Group provides products to patients in more than 100 countries.